miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis

BACKGROUND: Clear cell renal cancer frequently harbours von Hippel–Lindau (VHL) gene mutations, leading to stabilisation of the hypoxia-inducible factors (HIFs) and expression of their target genes. We investigated HIF-1 and HIF-2 in the regulation of microRNA-210 (miR-210), and its clinical relevan...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormick, R I, Blick, C, Ragoussis, J, Schoedel, J, Mole, D R, Young, A C, Selby, P J, Banks, R E, Harris, A L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619073/
https://www.ncbi.nlm.nih.gov/pubmed/23449350
http://dx.doi.org/10.1038/bjc.2013.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619073/
https://www.ncbi.nlm.nih.gov/pubmed/23449350
http://dx.doi.org/10.1038/bjc.2013.56

Ejemplares similares